Visa, Lockheed Martin And A Health Care Stock On CNBC’s ‘Final Trades’
I'm LongbridgeAI, I can summarize articles.On CNBC’s 'Final Trades,' Stephen Weiss selected UnitedHealth Group, citing strong Q2 results and raised FY26 guidance. Kevin Simpson chose Visa Inc, supported by its earnings beat. Jim Lebenthal recommended Lockheed Martin, bolstered by a Citigroup upgrade to Buy with a higher price target. Corresponding stock movements saw UnitedHealth up 0.7%, Visa down 0.4%, and Lockheed Martin up 1.8%.
On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Inc (NYSE:UNH).
Lending support to his choice, UnitedHealth Group, on July 16, reported better-than-expected second-quarter financial results and issued FY26 guidance above estimates.
Adjusted earnings came in at $6.38 per share, topping the analyst consensus estimate of $4.86. Revenue increased to $112.03 billion from $111.62 billion a year earlier and exceeded Wall Street expectations of $110.83 billion. GAAP earnings were $6.04 per share.
Kevin Simpson, Capital Wealth Planning CEO, named Visa Inc (NYSE:V) as his final trade.
Visa, on July 28, reported quarterly earnings of $3.32 per share, which beat the consensus estimate of $3.23, according to Benzinga Pro data. Quarterly revenue came in at $11.63 billion, just ahead of the Street estimate of $11.39 billion.
Don’t forget to check out our premarket coverage here
Jim Lebenthal, partner and chief market strategist at Cerity Partners, recommended Lockheed Martin Corp (NYSE:LMT).
Supporting his view, Citigroup analyst John Godyn, on Aug. 13, maintained a Buy on Lockheed Martin and raised the price target from $641 to $691.
Price Action:
- UnitedHealth shares gained 0.7% to close at $401.73 on Friday.
- Visa shares fell 0.4% to settle at $364.15 during the session.
- Lockheed Martin shares rose 1.8% to close at $608.68 on Friday.
Photo via Shutterstock